Alpha 2.0
Login Register
» Articles » PMID: 20433360

Pharmacokinetics of the Treatment Switch from Efavirenz to Nevirapine

Overview
Journal Clin Infect Dis
Publisher Oxford University Press
Specialty Infectious Diseases
Date 2010 May 4
PMID 20433360
Citations 2
Authors
Jean-Jacques Parienti
Gilles Peytavin
Veronique Reliquet
Renaud Verdon
Antoine Coquerel
Affiliations
Soon will be listed here.
Citing Articles

Use of in vitro to in vivo extrapolation to predict the optimal strategy for patients switching from efavirenz to maraviroc or nevirapine.

Schipani A, Back D, Owen A, Davies G, Khoo S, Siccardi M Clin Pharmacokinet. 2014; 54(1):107-16.

PMID: 25245943 DOI: 10.1007/s40262-014-0184-8.

A systematic review of the impact of alcohol use disorders on HIV treatment outcomes, adherence to antiretroviral therapy and health care utilization.

Azar M, Springer S, Meyer J, Altice F Drug Alcohol Depend. 2010; 112(3):178-93.

PMID: 20705402 PMC: 2997193. DOI: 10.1016/j.drugalcdep.2010.06.014.